GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML).
about
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 studyTimed sequential chemotherapy with concomitant granulocyte colony-stimulating factor for high-risk acute myelogenous leukemia: a single arm clinical trialMathematical modeling of the impact of cytokine response of acute myeloid leukemia cells on patient prognosis.
P2860
GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML).
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
GM-CSF in a double-blind rando ...... acute myeloid leukemia (AML).
@ast
GM-CSF in a double-blind rando ...... acute myeloid leukemia (AML).
@en
type
label
GM-CSF in a double-blind rando ...... acute myeloid leukemia (AML).
@ast
GM-CSF in a double-blind rando ...... acute myeloid leukemia (AML).
@en
prefLabel
GM-CSF in a double-blind rando ...... acute myeloid leukemia (AML).
@ast
GM-CSF in a double-blind rando ...... acute myeloid leukemia (AML).
@en
P2093
P1433
P1476
GM-CSF in a double-blind rando ...... o acute myeloid leukemia (AML)
@en
P2093
Lindemann A
Mertelsmann R
P577
1995-01-01T00:00:00Z